{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:53:26Z","timestamp":1769579606832,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,31]]},"DOI":"10.1093\/ageing\/afaf158","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T22:57:52Z","timestamp":1749509872000},"source":"Crossref","is-referenced-by-count":1,"title":["Bleeding risk scores in atrial fibrillation\u2014how should they influence decision-making for anticoagulants?"],"prefix":"10.1093","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-3185","authenticated-orcid":false,"given":"Anneka","family":"Mitchell","sequence":"first","affiliation":[{"name":"Department of Life Sciences, University of Bath , Bath ,","place":["UK"]},{"name":"Pharmacy Department, University Hospitals Plymouth NHS Trust , Plymouth ,","place":["UK"]},{"name":"ReMind UK (Research Institute for Brain Health) , Bath ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"McGrogan","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Bath , Bath ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"2025070304270674700_ref1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","article-title":"Epidemiology of atrial fibrillation: European perspective","volume":"6","author":"Zoni-Berisso","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2025070304270674700_ref2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"2025070304270674700_ref3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"2025070304270674700_ref4","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025070304270674700_ref5","doi-asserted-by":"publisher","first-page":"e008643-e","DOI":"10.1161\/JAHA.118.008643","article-title":"Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with non-valvular atrial fibrillation","volume":"7","author":"Martinez","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025070304270674700_ref6","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2025070304270674700_ref7","volume-title":"NG196: Atrial Fibrillation: Diagnosis and Management","author":"National Institute for Health Care Excellence (NICE)","year":"2021"},{"key":"2025070304270674700_ref8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12916-021-02067-5","article-title":"Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study","volume":"19","author":"Mitchell","year":"2021","journal-title":"BMC Med"},{"key":"2025070304270674700_ref9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/heartjnl-2024-324763","article-title":"Safety and effectiveness of anticoagulation therapy in older people with atrial fibrillation during exposed and unexposed treatment periods","volume":"111","author":"Mitchell","year":"2025","journal-title":"Heart"},{"key":"2025070304270674700_ref10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2025070304270674700_ref11","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1093\/eurheartj\/ehv476","article-title":"The ORBIT bleeding score: A simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O'Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"2025070304270674700_ref12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (anticoagulation and risk factors in atrial fibrillation) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025070304270674700_ref13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of atrial fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"2025070304270674700_ref14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"},{"key":"2025070304270674700_ref15","article-title":"A new bleeding risk score specifically developed for direct oral anticoagulants in a geriatric population","year":"2025","journal-title":"Age Ageing"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/6\/afaf158\/63458481\/afaf158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/54\/6\/afaf158\/63458481\/afaf158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T08:27:14Z","timestamp":1751531234000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf158\/8159129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf158","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,31]]},"article-number":"afaf158"}}